The project is a new project invested by the government, and it is also the * new preparation R&D and industrialization platform in South China that focuses on the R&D and production of national * chemical preparations. Driven by the new drug delivery system technology (DDS), the base mainly focuses on the research and industrialization development of new sustained and controlled release preparations and national * chemical * end preparations. The planned total area of the base is 25000 square meters, with a total investment of about 400 million yuan. It has a comprehensive preparation factory, administrative, research and development, quality control center, intelligent warehousing and logistics center, etc. The base is expected to be completed and put into use in 2019. The production capacity of solid preparations at the base can reach 3 billion tablets (granules) per year, and the production capacity of injections can reach 30 million tubes per year, with an annual operating revenue of about 1 billion yuan.

As the bridge product supplier of the project, Zhenda Group, since 1999, is a modern enterprise focusing on the design, R&D, production, sales and service of Bus duct, cable bridge, distribution cabinet, seismic support and hanger products. The company's products are widely used in data communication, energy and chemical engineering, research and development and manufacturing, power grid, commercial, residential, cultural and tourism, municipal public construction, warehousing and logistics, education and treatment projects.